loadpatents
name:-0.011412858963013
name:-0.010240077972412
name:-0.0015280246734619
Boyce; Christopher W. Patent Filings

Boyce; Christopher W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Boyce; Christopher W..The latest application filed is for "methods for preparing stabilized amorphous drug formulations using acoustic fusion".

Company Profile
1.33.37
  • Boyce; Christopher W. - Flemington NJ
  • Boyce; Christopher W. - Kenilworth NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods for preparing stabilized amorphous drug formulations using acoustic fusion
Grant 11,344,496 - Leung , et al. May 31, 2
2022-05-31
Methods For Preparing Stabilized Amorphous Drug Formulations Using Acoustic Fusion
App 20210154138 - Leung; Dennis H. ;   et al.
2021-05-27
Compounds that are ERK inhibitors
Grant 10,759,805 - Lim , et al. Sep
2020-09-01
Novel Compounds That Are Erk Inhibitors
App 20180319804 - Lim; Jongwon ;   et al.
2018-11-08
Compounds that are ERK inhibitors
Grant 10,065,967 - Lim , et al. September 4, 2
2018-09-04
Novel Compounds That Are Erk Inhibitors
App 20170320882 - Lim; Jongwon ;   et al.
2017-11-09
Compounds that are ERK inhibitors
Grant 9,745,307 - Lim , et al. August 29, 2
2017-08-29
Quinoxalines and AZA-quinoxalines as CRTH.sub.2 receptor modulators
Grant 9,469,615 - Boyce , et al. October 18, 2
2016-10-18
Quinolines and aza-quinolines as CRTH.sub.2 receptor modulators
Grant 9,290,453 - Boyce , et al. March 22, 2
2016-03-22
Novel Compounds That Are Erk Inhibitors
App 20160068532 - Lim; Jongwon ;   et al.
2016-03-10
Compounds that are ERK inhibitors
Grant 9,023,865 - Lim , et al. May 5, 2
2015-05-05
Quinazolinone-type compounds as CRTH.sub.2 antagonists
Grant 8,927,559 - Aslanian , et al. January 6, 2
2015-01-06
Novel Compounds That Are Erk Inhibitors
App 20140296203 - Lim; Jongwon ;   et al.
2014-10-02
Quinoxalines And Aza-quinoxalines As Crth2 Receptor Modulators
App 20130303517 - Boyce; Christopher W. ;   et al.
2013-11-14
Quinolines And Aza-quinolines As Crth2 Receptor Modulators
App 20130296300 - Boyce; Christopher W. ;   et al.
2013-11-07
Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulators
Grant 8,569,312 - McCormick , et al. October 29, 2
2013-10-29
Biaryl-spiroaminooxzaoline Analogues As Alpha 2c Adrenergic Receptor Modulators
App 20130225582 - McCormick; Kevin D. ;   et al.
2013-08-29
Quinazolinone-type Compounds As Crth2 Antagonists
App 20130210805 - Aslanian; Robert G. ;   et al.
2013-08-15
Functionally selective alpha2C adrenoreceptor agonists
Grant 8,501,747 - de lera Ruiz , et al. August 6, 2
2013-08-06
Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators
Grant 8,476,274 - McCormick , et al. July 2, 2
2013-07-02
Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonists
Grant 8,470,863 - Zheng , et al. June 25, 2
2013-06-25
Reversed Biaryl Spiroaminooxazoline Analogues As Alpha2c Adrenergic Receptor Modulators
App 20130079271 - McCormick; Kevin D. ;   et al.
2013-03-28
Functionally selective alpha2C adrenoreceptor agonists
Grant 8,383,818 - Zheng , et al. February 26, 2
2013-02-26
Biaryl Spiroaminooxazoline Analogues As Alpha2c Adrenergic Receptor Modulators
App 20130045914 - McCormick; Kevin D. ;   et al.
2013-02-21
Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulators
Grant 8,324,213 - McCormick , et al. December 4, 2
2012-12-04
Functionally Selective Azanitrile Alpha-2c Adrenoreceptor Agonists
App 20120028940 - Boyce; Christopher W. ;   et al.
2012-02-02
Biaryl-spiroaminooxazoline Analogues As Alpha 2c Adrenergic Receptor Modulators
App 20110251207 - McCormick; Kevin D. ;   et al.
2011-10-13
Functionally selective ALPHA2C adrenoreceptor agonists
Grant 8,017,642 - Yu , et al. September 13, 2
2011-09-13
Functionally selective ALPHA2C adrenoreceptor agonists
Grant 8,003,624 - McCormick , et al. August 23, 2
2011-08-23
Cyclopropylchromene Derivatives As Modulators Of The Alpha-2c Receptor
App 20110190247 - Yu; Younong ;   et al.
2011-08-04
ALPHA2C adrenoreceptor agonists
Grant 7,985,748 - McCormick , et al. July 26, 2
2011-07-26
Tricyclic Spirocycle Derivatives And Methods Of Use
App 20110166124 - McCormick; Kevin D. ;   et al.
2011-07-07
Functionally Selective Alpha2C Adrenoreceptor Agonists
App 20110060006 - Zheng; Junying ;   et al.
2011-03-10
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H.sub.3 antagonists
Grant 7,846,946 - Aslanian , et al. December 7, 2
2010-12-07
Functionally selective alpha2C adrenoreceptor agonists
Grant 7,803,828 - McCormick , et al. September 28, 2
2010-09-28
Functionally Selective Alpha2c Adrenoreceptor Agonists
App 20100197562 - De lera Ruiz; Manuel ;   et al.
2010-08-05
Alpha2c Adrenoreceptor Agonists
App 20100173823 - McCormick; Kevin D. ;   et al.
2010-07-08
Derivatives And Analogs Of Chroman As Functionally Selective Alpha2c Adrenoreceptor Agonists
App 20100168195 - Zheng; Junying ;   et al.
2010-07-01
Functionally Selective Alpha2c Adrenoreceptor Agonists
App 20100144816 - McCormick; Kevin D. ;   et al.
2010-06-10
.alpha.2C adrenoreceptor agonists
Grant 7,700,592 - McCormick , et al. April 20, 2
2010-04-20
Phenoxypiperidines and analogs thereof useful as histamine H.sub.3 antagonists
Grant 7,638,531 - Mutahi , et al. December 29, 2
2009-12-29
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H.sub.3 antagonists
Grant 7,635,705 - Aslanian , et al. December 22, 2
2009-12-22
Heteroatom-linked Substituted Piperidines And Derivatives Thereof Useful As Histamine H3 Antagonists
App 20090286830 - Aslanian; Robert G. ;   et al.
2009-11-19
Novel Non-imidazole Compounds
App 20080119487 - Aslanian; Robert G. ;   et al.
2008-05-22
Alpha2C adrenoreceptor agonists
App 20080039439 - McCormick; Kevin D. ;   et al.
2008-02-14
Functionally selective alpha2C adrenoreceptor agonists
App 20080027100 - McCormick; Kevin D. ;   et al.
2008-01-31
Non-imidazole compounds
Grant 7,300,941 - Aslanian , et al. November 27, 2
2007-11-27
Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists
App 20070167435 - Mutahi; Mwangi W. ;   et al.
2007-07-19
Benzimidazolone histamine H.sub.3 antagonists
Grant 7,220,735 - Ting , et al. May 22, 2
2007-05-22
Functionally selective alpha2C adrenoreceptor agonists
App 20070099872 - McCormick; Kevin D. ;   et al.
2007-05-03
Alpha2C adrenoreceptor agonists
App 20070093477 - McCormick; Kevin D. ;   et al.
2007-04-26
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
App 20070015807 - Aslanian; Robert G. ;   et al.
2007-01-18
Benzimidazole derivatives useful as histamine H3 antagonists
Grant 7,105,505 - Zeng , et al. September 12, 2
2006-09-12
Benzimidazole derivatives useful as histamine H3 antagonists
App 20040097483 - Zeng, Qingbei ;   et al.
2004-05-20
Novel non-imidazole compounds
App 20040097513 - Aslanian, Robert G. ;   et al.
2004-05-20
Non-imidazole compounds
Grant 6,720,328 - Aslanian , et al. April 13, 2
2004-04-13
Benzimidazolone histamine H3 antagonists
App 20040048843 - Ting, Pauline C. ;   et al.
2004-03-11
Novel non-imidazole compounds
App 20030045519 - Aslanian, Robert G. ;   et al.
2003-03-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed